Delta Asia International Corporation (TPEX:6762)
195.00
+2.00 (1.04%)
Oct 31, 2025, 1:30 PM CST
Delta Asia International Revenue
Delta Asia International had revenue of 175.52M TWD in the quarter ending September 30, 2025, with 5.97% growth. This brings the company's revenue in the last twelve months to 711.19M, up 39.69% year-over-year. In the year 2024, Delta Asia International had annual revenue of 580.51M with 14.27% growth.
Revenue (ttm)
711.19M
Revenue Growth
+39.69%
P/S Ratio
9.64
Revenue / Employee
3.89M
Employees
183
Market Cap
6.86B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 580.51M | 72.49M | 14.27% |
| Dec 31, 2023 | 508.02M | 45.05M | 9.73% |
| Dec 31, 2022 | 462.97M | -68.34M | -12.86% |
| Dec 31, 2021 | 531.32M | -23.00M | -4.15% |
| Dec 31, 2020 | 554.31M | 170.94M | 44.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.90B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |
| Caliway Biopharmaceuticals | 44.83M |